Oxaliplatin, a platinum-based chemotherapy agent, is commonly used in the treatment of various malignancies. Common adverse effects involve neurological, hematological, gastrointestinal system, and hypersensitivity, and rarely ocular changes have also been reported. We describe the case of a 71-year-old male, who developed reversible ocular toxicity after receiving oxaliplatin for treatment for pancreatic cancer.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605969 | PMC |
| http://dx.doi.org/10.7759/cureus.4582 | DOI Listing |
Publication Analysis
Top Keywords
reversible ocular
8
ocular toxicity
8
toxicity oxaliplatin
4
oxaliplatin case
4
case report
4
report oxaliplatin
4
oxaliplatin platinum-based
4
platinum-based chemotherapy
4
chemotherapy agent
4
agent commonly
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!